Author： Poncy Jean-Luc Gault Nathalie Lefaix Jean-Louis
Publisher： NRC Research Press
ISSN： 1205-7541
Source： Canadian Journal of Physiology and Pharmacology, Vol.82, Iss.1, 2004-01, pp. : 38-49
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Levocetirizine superior to loratadine for SAR, on a par for PAR
Inpharma, Vol. 1, Iss. 1450, 2004-01 ,pp. :
Access to resources
Recommend
Olanzapine and risperidone on a par in schizophrenia
Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. :
Olanzapine and risperidone on a par in schizophrenia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :
Role of PAR2 in pain and inflammation
Trends in Pharmacological Sciences, Vol. 23, Iss. 4, 2002-04 ,pp. :
Levocetirizine improves HRQOL in children with PAR
Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. :